BROADWIND, INC. Debt Disclosure
10. DEBT AND CREDIT AGREEMENTS
The Company’s outstanding debt balances as of December 31, 2024 and 2023 consisted of the following:
| December 31, | ||||||||
| 2024 | 2023 | |||||||
| Line of credit | $ | — | $ | 4,657 | ||||
| Other notes payable | 1,618 | 1,361 | ||||||
| Long-term debt | 7,578 | 6,135 | ||||||
| Total debt | 9,196 | 12,153 | ||||||
| Less: current maturities | (1,454 | ) | (5,903 | ) | ||||
| Long-term debt, net of current maturities | $ | 7,742 | $ | 6,250 | ||||
As of December 31, 2024, future annual principal payments on the Company’s outstanding debt obligations were as follows:
| 2025 | $ | 1,454 | ||
| 2026 | 1,478 | |||
| 2027 | 5,835 | |||
| 2028 | 382 | |||
| 2029 | 47 | |||
| Total | $ | 9,196 |
Credit Facilities
On August 4, 2022, the Company entered into a credit agreement (as amended, the “2022 Credit Agreement”) with Wells Fargo Bank, National Association, as lender (“Wells Fargo”), which replaced its prior credit facility and provided the Company and its subsidiaries with a $35,000 senior secured revolving credit facility (which may be further increased by up to an additional $10,000 upon the request of the Company and at the sole discretion of Wells Fargo) and a $7,578 senior secured term loan (collectively, as amended, the “2022 Credit Facility”). The proceeds of the 2022 Credit Facility are available for general corporate purposes, including strategic growth opportunities. Net deferred financing costs related to the 2022 Credit Facility which primarily relate to the revolving credit loan, were $269 at December 31, 2024, which is net of accumulated amortization of $251. Net deferred financing costs at December 31, 2023 were $359, which is net of accumulated amortization of $141. These costs are included in the “Other assets” line item of the Company's consolidated financial statements at December 31, 2024 and December 31, 2023.
On February 8, 2023, the Company executed Amendment No. 1 to Credit Agreement and Limited Waiver which waived the Company’s fourth quarter minimum EBITDA (as defined in the 2022 Credit Agreement) requirement for the period ended December 31, 2023, amended the Fixed Charge Coverage Ratio (as defined in the 2022 Credit Agreement) requirements for the twelve-month period ending January 31, 2024 through and including June 30, 2024 and each twelve-month period thereafter, and amended the minimum EBITDA requirements applicable to the twelve-month periods ending March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.
On December 19, 2024, the Company executed Amendment No. 2 to Credit Agreement, which (1) increased the outstanding principal amount of the term loan to $7,578 and restarted the 84-month amortization period, and (2) amended the Fixed Charge Coverage Ratio (as defined in the 2022 Credit Agreement) from to for each twelve-month period ending January 31, 2024 through and including December 31, 2025. Proceeds from the increased amount of the term loan were used to repay the Company’s indebtedness under its existing revolving line of credit with Wells Fargo and related fees and expenses, thereby allowing for increased availability under the existing revolving line of credit.
The 2022 Credit Agreement, as amended, contains customary covenants limiting the Company’s and its subsidiaries’ ability to, among other things, incur liens, make investments, incur indebtedness, merge or consolidate with others or dispose of assets, change the nature of its business, and enter into transactions with affiliates. The initial term of the revolving credit facility matures August 4, 2027. The term loan also matures on August 4, 2027, with monthly payments based on an 84-month amortization, with the remaining principal and accrued interest due at maturity.
As of December 31, 2024, there was $7,578 of outstanding indebtedness under the 2022 Credit Facility, with the ability to borrow an additional $24,901. As of December 31, 2024, the Company was in compliance with all financial covenants under the 2022 Credit Facility. As of December 31, 2024, the effective interest rate of the senior secured revolving credit facility was 6.71% and the effective rate of the senior secured term loan was 6.96%. As of December 31, 2023, the effective interest rate of the senior secured revolving credit facility was 7.64% and the effective rate of the senior secured term loan was 7.89%.
Other
The Company has outstanding notes payable for capital expenditures in the amount of $1,618 and $1,361 as of December 31, 2024 and 2023, respectively, with $371 and $163 included in the “Line of credit and current maturities of long-term debt” line item of the Company’s consolidated financial statements as of December 31, 2024 and 2023, respectively. The notes payable have monthly payments that range from $1 to $20 and a weighted average interest rate of 7%. The equipment purchased is utilized as collateral for the notes payable. The outstanding notes payable have maturity dates that range from September 2028 to June 2029.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Mar 5, 2025 | Showing above |
| 2015 | Feb 26, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.